Altimmune, Inc.
ALT
$3.42
$0.000.00%
NASDAQ
Corporate Info
Website
Phone Number
240 654 1450
Address
910 Clopper Road
Suite 201S
Gaithersburg, MD 20878
Suite 201S
Gaithersburg, MD 20878
Country
United States
Year Founded
1997
Details
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Employees
Business Description
Altimmune, Inc., a late clinical stage biopharmaceutical company, focuses on developing novel therapies for serious liver diseases. Its lead product candidate is pemvidutide, a GLP-1/glucagon dual receptor agonist, which is in Phase 3 clinical trial for the treatment of metabolic dysfunction-associated steatohepatitis, alcohol use disorder, and alcohol-associated liver disease. The company was founded in 1997 and is headquartered in Gaithersburg, Maryland.